🇮🇳IN
Sign In
PP

PPLPHARMA

NSE

Piramal Pharma Ltd

₹191.07

-3.92(-2.01%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

PPLPHARMA valuation summary

Piramal Pharma Ltd trades at 36.2 times trailing earnings. Return on equity is 9.8% and return on capital employed is 11.8%. The dividend yield is 0.07%.

P/E36.2
ROE9.8%
ROCE11.8%
Dividend yield0.07%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer